Former Republican Presidential Hopeful Vivek Ramaswamy Acquires Activist Stake in BuzzFeed [Yahoo! Finance]
Roivant Sciences Ltd. (ROIV)
Company Research
Source: Yahoo! Finance
Vivek Ramaswamy, the entrepreneur who ran an unsuccessful campaign for the 2024 Republican presidential nomination, has acquired a significant stake in the digital media company, with an SEC filing indicating that he intends to pursue an activist approach. More from The Hollywood Reporter BuzzFeed to Lay Off 16 Percent of Its Workforce In Major Cuts BuzzFeed Sells Complex to Live Stream Shopping Platform NTWRK in $109M Deal FilmRise Nabs BuzzFeed Studios Library Series, Including 'Hot Ones' Ramaswamy dropped out of the GOP presidential race after the Iowa Caucus, and endorsed former President Donald Trump. According to an SEC filing , Ramaswamy owns shares and call options worth just under $4 million, and equivalent to about 7.7% of BuzzFeed shares. “The Reporting Person believes the securities of the Issuer are undervalued and represent an attractive investment opportunity,” the filing continues, adding that Ramaswamy “will seek to engage in a dialogue with the Issuer'
Show less
Read more
Impact Snapshot
Event Time:
ROIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ROIV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ROIV alerts
High impacting Roivant Sciences Ltd. news events
Weekly update
A roundup of the hottest topics
ROIV
News
- Roivant Sciences Ltd. (NASDAQ: ROIV) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Roivant Sciences Ltd. (NASDAQ: ROIV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.MarketBeat
- Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%GlobeNewswire
- FOX Nation Taps Vivek Ramaswamy to Host New Series "Truths with Vivek Ramaswamy" Premiering September 22 [Yahoo! Finance]Yahoo! Finance
- Roivant Sciences Ltd. (NASDAQ: ROIV) had its price target raised by analysts at Bank of America Co. from $12.00 to $12.50. They now have a "neutral" rating on the stock.MarketBeat
ROIV
Earnings
- 8/8/24 - Beat
ROIV
Sec Filings
- 9/26/24 - Form 4
- 9/26/24 - Form 4
- 9/26/24 - Form 4
- ROIV's page on the SEC website